Left Atrial Appendage Closure and Concomitant Transcatheter Intervention: Can We?

Several scientific societies support performing left atrial appendage occlusion (LAAO) as a stand-alone procedure, even though it is often associated to other cardiomyopathies requiring transcatheter intervention. 

¿Es posible realizar simultáneamente cierre de la orejuela izquierda y otra intervención cardíaca percutánea?

Though still controversial, combining LAAO and any other cardiac intervention might reduce hospitalizations, as well as the need for additional punctures, anesthesia, red tape, a longer stay and higher costs at long term. 

This was a retrospective analysis of 88,990 patients undergoing LAAO, 1,225 (1.4%) undergoing LAAO and concomitant cardiac intervention (LAAO+).

Primary end point was defined as MACE, which included all-cause inhospital mortality or stroke.

Seeing as populations were not homogeneous, propensity score was used to match patients, which resulted in 1,220 patients in each group. 

Read also: Benefit of Cusp overlap method for self‐expanding transcatheter aortic valves.

Mean age was 75, 63% were men, 29% had diabetes, 82% hypertension, 37% smoked, 44% had heart disease, 11% peripheral vascular disease, 22% kidney function deterioration, 6% were in dialysis, 18% had COPD, 8% had suffered MI, 16% had experienced stroke or transient ischemic attack, 13% had a history of PCI or CABG. 

The most common cardiac intervention was ablation (73%), followed by TAVR (15.5%), pacemaker implantation (6.6%), and less frequently atrial septal defect or PFO closure, PCI, edge-to-edge repair or transcatheter mitral valve replacement. 

Primary events rate resulted similar (1.3% vs. 3.1%, adjusted OR: 1.82; CI 95%: 0.94-2.74, p=0.15) for LAAO and LAAO+. Neither were there significant differences in all-cause mortality, stroke, kidney failure, bleeding, need for transfusion, vascular complications and hospital stay; however, hospital costs were higher for LAAO+ patients.

Read also: Does Post-Dilation in TAVR Affect its Long-Term Outcomes?

Patients undergoing LAAO and TAVR showed higher rates of stroke and bleeding, while patients undergoing ablation for atrial fibrillation or atrial flutter exhibited higher incidence of AV blockage and need for pacemaker implantation. 

Conclusion

In this observational, retrospective study, the combination of LAAO + another cardiac intervention has been associated to similar MACE rate and length of stay. However, some complications appear to be more frequent and the cost of the combined procedures resulted higher. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Safety and Efficacy of Combining Left Atrial Appendage Occlusion With Another Cardiac Procedure.

Reference: Mahmoud Ismayl, et al. J Am Coll Cardiol Intv 2024;17:262–273).


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

TAVR in Small Annuli: What Valve Should We Use?

One of the major challenges of severe aortic stenosis are patients with small aortic annuli, defined as ≤430 mm² aortic valve area. This condition...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...

ACC 2025 | BHF PROTECT-TAVI: Are Cerebral Protection Systems Necessary in TAVI?

TAVI has seen a steady increase in use, though stroke continues to be one of its unwanted complications, mostly ischemic and, less frequently, hemorrhagic. The...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

SMART-CHOICE 3 | Efficacy and Safety of Clopidogrel vs Aspirin Monotherapy in High Risk Patients after Percutaneous Coronary Intervention

Courtesy of Dr. Juan Manuel Pérez. After post percutaneous coronary intervention (PCI) standard duration dual antiplatelet therapy (DAPT), the optimal long term monotherapy strategy is...

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Even though pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), up to 40% of patients are not candidates because...

iFR- vs. FFR-Guided Coronary Revascularization: 5-Year Clinical Outcomes

The assessment of coronary stenosis using coronary physiology has become a key tool in guiding revascularization. The two most widely used techniques are fractional...